Bioavailability of marine n-3 fatty acid formulations

Prostaglandins, Leukotrienes, and Essential Fatty Acids
J DyerbergE B Schmidt

Abstract

The use of marine n-3 polyunsaturated fatty acids (n-3 PUFA) as supplements has prompted the development of concentrated formulations to overcome compliance problems. The present study compares three concentrated preparations - ethyl esters, free fatty acids and re-esterified triglycerides - with placebo oil in a double-blinded design, and with fish body oil and cod liver oil in single-blinded arms. Seventy-two volunteers were given approximately 3.3g of eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) daily for 2 weeks. Increases in absolute amounts of EPA and DHA in fasting serum triglycerides, cholesterol esters and phospholipids were examined. Bioavailability of EPA+DHA from re-esterified triglycerides was superior (124%) compared with natural fish oil, whereas the bioavailability from ethyl esters was inferior (73%). Free fatty acid bioavailability (91%) did not differ significantly from natural triglycerides. The stereochemistry of fatty acid in acylglycerols did not influence the bioavailability of EPA and DHA.

References

Nov 1, 1992·Lipids·R G Ackman
May 1, 1991·The American Journal of Clinical Nutrition·D I SilvermanR C Pasternak
May 1, 1991·The American Journal of Clinical Nutrition·A NordøyL Hatcher
Apr 15, 1988·Biochemical and Biophysical Research Communications·L D Lawson, B G Hughes
Oct 1, 1988·The American Journal of Clinical Nutrition·W S HarrisC A Dujovne
Nov 20, 2002·Circulation·Penny M Kris-EthertonUNKNOWN American Heart Association. Nutrition Committee
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Oct 19, 2006·JAMA : the Journal of the American Medical Association·Dariush Mozaffarian, Eric B Rimm
Jan 21, 2010·JAMA : the Journal of the American Medical Association·Ramin Farzaneh-FarMary A Whooley

❮ Previous
Next ❯

Citations

Sep 6, 2011·Current Atherosclerosis Reports·Peter J GilliesPenny M Kris-Etherton
May 17, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jan Philipp Schuchardt, Andreas Hahn
Jan 4, 2013·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·Jeffrey T F AshleyDavid J Velinsky
Feb 28, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Clemens von Schacky
Feb 22, 2011·Lipids in Health and Disease·Kuo-Liong ChienMing-Fong Chen
Aug 21, 2012·Journal of Lipid Research·Donald B JumpSasmita Tripathy
Feb 26, 2014·Nutrients·Clemens von Schacky
Sep 21, 2013·International Journal of Cardiology·Franca Marangoni, Andrea Poli
Jul 24, 2014·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Christopher J GerlingLawrence L Spriet
Nov 10, 2013·Postgraduate Medicine·William S HarrisTerrance J Moran
May 21, 2013·Nutrition Research·Maria Elizabeth Pereira NobreGlauce Socorro de Barros Viana
Jun 1, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Hector L Lopez
Jul 6, 2011·Prostaglandins & Other Lipid Mediators·Clemens von Schacky
Apr 19, 2011·Appetite·Alexandra McManusWendy Newton
Nov 26, 2015·Trends in Molecular Medicine·Agnes LimLouis Tong
Mar 19, 2011·European Journal of Clinical Investigation·Gudrun V SkuladottirOlafur S Indridason
Dec 21, 2012·Journal of the Science of Food and Agriculture·Jenna C Sullivan RitterFabiola Jovica
Aug 21, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C MorinÉ Rousseau
Sep 1, 2015·Neurochemistry International·Kusumika GharamiSumantra Das
Aug 1, 2015·Cancer Metastasis Reviews·Seyed Fazel NabaviSeyed Mohammad Nabavi
Apr 4, 2015·Prostaglandins & Other Lipid Mediators·Sara BonafiniCristiano Fava
Feb 26, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Kaisa M LinderborgAndrew J Sinclair
Apr 24, 2012·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert K McNamara
Jun 18, 2014·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Clemens von Schacky
Aug 13, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Caroline MorinSamuel Fortin
Sep 15, 2014·Progress in Lipid Research·Samaneh GhasemifardAndrew J Sinclair
Nov 20, 2014·European Journal of Clinical Nutrition·H H HinriksdottirA Ramel
May 29, 2016·Regulatory Toxicology and Pharmacology : RTP·Kurt S TandeBarry S Lynch
Jul 22, 2016·Cornea·Alice T EpitropoulosHenry D Perry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.